These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34552921)

  • 1. Impact of Preanalytical and Analytical Methods on Cell-Free DNA Diagnostics.
    Krasic J; Abramovic I; Vrtaric A; Nikolac Gabaj N; Kralik-Oguic S; Katusic Bojanac A; Jezek D; Sincic N
    Front Cell Dev Biol; 2021; 9():686149. PubMed ID: 34552921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
    Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
    Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
    van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
    Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Quantification of Plasma Cell-Free DNA Using Different Manual and Automated Methods.
    Polatoglou E; Mayer Z; Ungerer V; Bronkhorst AJ; Holdenrieder S
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
    Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
    Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
    J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
    Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
    Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker.
    Raos D; Oršolić D; Mašić S; Tomić M; Krasić J; Tomašković I; Gabaj NN; Gelo N; Kaštelan Ž; Kuliš T; Bojanac AK; Barešić A; Ulamec M; Ježek D; Sincic N
    Epigenomics; 2022 Dec; 14(23):1493-1507. PubMed ID: 36722130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative comparison of cell-free DNA and cell-free fetal DNA isolation by four (semi-)automated extraction methods: impact in two clinical applications: chimerism quantification and noninvasive prenatal diagnosis.
    Pedini P; Graiet H; Laget L; Filosa L; Chatron J; Cherouat N; Chiaroni J; Hubert L; Frassati C; Picard C
    J Transl Med; 2021 Jan; 19(1):15. PubMed ID: 33407582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker.
    Ponti G; Maccaferri M; Mandrioli M; Manfredini M; Micali S; Cotugno M; Bianchi G; Ozben T; Pellacani G; Del Prete C; Tomasi A
    Pathol Oncol Res; 2018 Oct; 24(4):941-945. PubMed ID: 29730802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of methods for donor-derived cell-free DNA quantification in plasma and urine from solid organ transplant recipients.
    Kueng N; Arcioni S; Sandberg F; Kuhn C; Banz V; Largiadèr CR; Sidler D; Amstutz U
    Front Genet; 2023; 14():1089830. PubMed ID: 36777723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing.
    Pérez-Barrios C; Nieto-Alcolado I; Torrente M; Jiménez-Sánchez C; Calvo V; Gutierrez-Sanz L; Palka M; Donoso-Navarro E; Provencio M; Romero A
    Transl Lung Cancer Res; 2016 Dec; 5(6):665-672. PubMed ID: 28149760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
    Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
    Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients.
    Ponti G; Maccaferri M; Manfredini M; Kaleci S; Mandrioli M; Pellacani G; Ozben T; Depenni R; Bianchi G; Pirola GM; Tomasi A
    Clin Chim Acta; 2018 Apr; 479():14-19. PubMed ID: 29309771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma.
    de Kock R; Deiman B; Kraaijvanger R; Scharnhorst V
    J Mol Diagn; 2019 Sep; 21(5):895-902. PubMed ID: 31229652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.
    Lee EY; Lee EJ; Yoon H; Lee DH; Kim KH
    Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32325682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis.
    Ponti G; Maccaferri M; Manfredini M; Micali S; Torricelli F; Milandri R; Del Prete C; Ciarrocchi A; Ruini C; Benassi L; Bettelli S; Kaleci S; Ozben T; Tomasi A
    Clin Chim Acta; 2019 Oct; 497():76-80. PubMed ID: 31301282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples.
    Peng H; Pan M; Zhou Z; Chen C; Xing X; Cheng S; Zhang S; Zheng H; Qian K
    Front Cell Dev Biol; 2024; 12():1385041. PubMed ID: 38784382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy with cell free DNA: new horizons for prostate cancer.
    Ponti G; Maccaferri M; Percesepe A; Tomasi A; Ozben T
    Crit Rev Clin Lab Sci; 2021 Jan; 58(1):60-76. PubMed ID: 32805148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.